RxDoctor Payments Data

Mitchell Sanders

Physician Assistant · Carbondale, ILNPI 1528680162

Payments from drug & device makers

$1,821in general payments, 2019–2025

Across 108 payments — averaging $16.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$463
  • AbbVie$263
  • AstraZeneca$177
  • Novartis$127
  • Mylan Specialty L.p.$117
  • GSK$104
  • plus $570 from 18 others

What the payments were for

  • Food & beverage$1,821100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,821 in reported general payments places this provider in the 80th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$183
Medicare patients
11
Services billed
17

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide81$92,360
EliquisApixaban58$61,371
JardianceEmpagliflozin42$51,434
TrulicityDulaglutide36$42,546
JanuviaSitagliptin Phosphate28$29,341
MounjaroTirzepatide24$29,183
Breztri AerosphereBudesonide/Glycopyr/Formoterol36$23,312
FarxigaDapagliflozin Propanediol18$20,010
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$19,101
RexultiBrexpiprazole12$17,034
TradjentaLinagliptin24$14,922
Repatha SureclickEvolocumab19$12,587
LinzessLinaclotide17$9,908
MyrbetriqMirabegron14$6,959
DuleraMometasone/Formoterol13$5,477

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$463$92,36081 claims
Lilly USA, LLCTrulicity, Mounjaro$77$71,72960 claims
AstraZenecaBreztri Aerosphere, Farxiga$177$43,32254 claims
GSKTrelegy Ellipta$104$19,10127 claims
Otsuka America Pharmaceutical, Inc.Rexulti$51$17,03412 claims
AbbVieLinzess$263$9,90817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Carbondale

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →